JORGE MENA: Open Payments
NPI 1891233037 · DEPEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,052 in 58 payments from 22 companies in 2025. Trend: 2023 $395 · 2024 $3,285 · 2025 $2,052
Food & beverage: $1,052Long term medical supply or device loan: $1,000
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $1,196 |
| AstraZeneca Pharmaceuticals LP | 6 | $126 |
| Incyte Corporation | 3 | $76 |
| Janssen Biotech, Inc. | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Daiichi Sankyo Inc. | 3 | $71 |
| ABBVIE INC. | 3 | $68 |
| GENZYME CORPORATION | 3 | $57 |
| Genentech USA, Inc. | 2 | $40 |
| Eisai Inc. | 2 | $35 |
Products named: KISQALI, Enhertu, SCEMBLIX, SARCLISA, RYBREVANT, EPKINLY, MONJUVI, NINLARO.
Industry payments across NY — which companies pay providers there.
